Health
Foresight Diagnostics to demonstrate utility of PhasED-Seq technology at ICML meeting – News-Medical.Net
Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance…
Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance of its minimal residual disease (MRD) detection platform in diffuse large B-cell lymphoma (DLBCL) will be presented at the 16th…
Continue Reading
-
General16 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News23 hours agoBarn-owl project reducing farmers’ reliance on poison to manage rats and mice
-
Noosa News20 hours agoSouth-west Queensland highway closed after truck carrying oxygen cylinders catches fire
-
Noosa News15 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba